Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02388386 · ClinicalTrials.gov registry record · NA
Monitoring Medication Adherence in Left Ventricular Assist Device Recipients
A NA study, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02388386 is a NA study that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 10 participants.
The verdict
NCT02388386, a NA study, has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators aim to develop a novel and wireless method for monitoring medication adherence among heart failure patients with left ventricular assist devices (LVADs). Proteus Digital™ has developed an ingestible and bio-absorbable micro-sensor as a strategy to monitor medication compliance. The edible sensor has at its core a silicon-based integrated circuit measuring 1.0 mm x 0.45 mm and is imbedded on a pill. Once ingested, this circuit is activated by gastric acid resulting in an electrochemical redox reaction and an electrical charge that is transmitted to a patch worn over the abdomen and wirelessly to a portable device such as a smart phone. This strategy of medication adherence differs from conventional adherence monitoring including pill counting and patient-recall by precisely tracking medication ingestion.
Interventions
- DEVICE PROTEUS-SENSOR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02388386
The ClinicalTrials.gov registry entry for NCT02388386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PROTEUS-SENSOR is the first listed.
NCT02388386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02388386 about?
NCT02388386 is a clinical study titled "Monitoring Medication Adherence in Left Ventricular Assist Device Recipients". The investigators aim to develop a novel and wireless method for monitoring medication adherence among heart failure patients with left ventricular assist devices (LVADs). Proteus Digital™ has developed an ingestible and bio-absorbable micro-sensor as a strategy to monitor medication compliance. The...
What is the current status of trial NCT02388386?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-02. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02388386?
The interventions under investigation include: PROTEUS-SENSOR (DEVICE).
Who is sponsoring clinical trial NCT02388386?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.